Francisco M. Marty
Brigham and Women's Hospital(US)Harvard University(US)Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Antifungal resistance and susceptibility, Cytomegalovirus and herpesvirus research, Fungal Infections and Studies, Polyomavirus and related diseases, Herpesvirus Infections and Treatments
Most-Cited Works
- → Remdesivir for 5 or 10 Days in Patients with Severe Covid-19(2020)1,431 cited
- → Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19(2020)1,265 cited
- → Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients(2021)1,256 cited
- → Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation(2017)1,163 cited
- → Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis(2016)679 cited
- → Transmission of Lymphocytic Choriomeningitis Virus by Organ Transplantation(2006)530 cited